$84.81
-1.52-1.77%
Last update: Aug 31, 7:46 AM
$84.13
-2.20-2.55%
GeneDx Holdings Corp
WGSNASDAQ
GeneDx Holdings Earnings & Forecasts
GeneDx Holdings (WGS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
GeneDx Holdings Guidance
GeneDx Holdings (WGS) last issued guidance on August 3, 2026 for fiscal year 2026. The company guided revenue in the range of $475M - $490M for the period.
Compared to prior guidance, GeneDx Holdings maintained its revenue forecast from a prior range of $475M - $490M.
GeneDx Holdings has issued 18 guidance updates between March 14, 2023 and August 3, 2026. During this period, the company raised its outlook 9 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.19 | $-0.03 | $0.12 | $0.37 |
| Actual | $0.01 | $-0.28 | $0.14 | $0.49 |
| Surprise | +105.3% | -833.3% | +16.7% | +32.4% |
| Revenue | ||||
| Estimate | $110.7M | $112.1M | $119.9M | $104.3M |
| Actual | $114.4M | $102.3M | $121.0M | $116.7M |
| Surprise | +3.33% | -8.71% | +0.87% | +11.9% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.07 | $0.31 | $0.10 | $0.25 |
| Revenue | ||||
| Consensus | $122.8M | $141.6M | — | — |
